Pregabalin In Partial Seizures Extension Study

PHASE3CompletedINTERVENTIONAL
Enrollment

227

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

September 30, 2007

Conditions
Seizures
Interventions
DRUG

Pregabalin

Pregabalin

Trial Locations (47)

1070

Pfizer Investigational Site, Brussels

4000

Pfizer Investigational Site, Liège

5530

Pfizer Investigational Site, Yvoir

9000

Pfizer Investigational Site, Ghent

9500

Pfizer Investigational Site, Ponta Delgada

13009

Pfizer Investigational Site, Marseille 13

13385

Pfizer Investigational Site, Marsille

31043

Pfizer Investigational Site, Toulouse

33076

Pfizer Investigational Site, Bordeaux

33520

Pfizer Investigational Site, Tampere

34295

Pfizer Investigational Site, Montpellier

35033

Pfizer Investigational Site, Rennes

37044

Pfizer Investigational Site, Tours

38043

Pfizer Investigational Site, Grenoble

54000

Pfizer Investigational Site, Nancy

59037

Pfizer Investigational Site, Lille

64109

Pfizer Investigational Site, Bayonne

67091

Pfizer Investigational Site, Strasbourg

69694

Pfizer Investigational Site, Lyon

70210

Pfizer Investigational Site, Kuopio

75019

Pfizer Investigational Site, Paris

75651

Pfizer Investigational Site, Paris

75674

Pfizer Investigational Site, Paris

Pfizer Investigational Site, Paris

B-8000

Pfizer Investigational Site, Bruges

B-2570

Pfizer Investigational Site, Duffel

B-3000

Pfizer Investigational Site, Leuven

B-8700

Pfizer Investigational Site, Tielt

00250

Pfizer Investigational Site, Helsinki

Cedex 06002

Pfizer Investigational Site, Nice

40-635

Pfizer Investigational Site, Katowice

31-523

Pfizer Investigational Site, Krakow

27-718

Pfizer Investigational Site, Lublin

00-416

Pfizer Investigational Site, Warsaw

02-097

Pfizer Investigational Site, Warsaw

02-957

Pfizer Investigational Site, Warsaw

50-420

Pfizer Investigational Site, Wroclaw

4701-965

Pfizer Investigational Site, Braga

3000-075

Pfizer Investigational Site, Coimbra

9000-168

Pfizer Investigational Site, Funchal

Unknown

Pfizer Investigational Site, Lisbon

4454-509

Pfizer Investigational Site, Matosinhos Municipality

9500-370

Pfizer Investigational Site, Ponta Delgada

4099-001

Pfizer Investigational Site, Porto

CH-1011

Pfizer Investigational Site, Lausanne

CH-8008

Pfizer Investigational Site, Zurich

CH-8091

Pfizer Investigational Site, Zurich

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00143130 - Pregabalin In Partial Seizures Extension Study | Biotech Hunter | Biotech Hunter